Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$126.87
+2.2%
$125.99
$93.17
$132.84
$30.65B0.662.48 million shs2.76 million shs
Cencora, Inc. stock logo
COR
Cencora
$253.88
-2.6%
$246.39
$214.77
$263.70
$49.23B0.511.36 million shs1.83 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$69.94
-4.1%
$74.77
$63.67
$82.49
$8.68B0.91.50 million shs1.56 million shs
McKesson Co. stock logo
MCK
McKesson
$640.93
-1.9%
$605.54
$464.42
$663.61
$80.32B0.52819,051 shs694,919 shs
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+2.11%-0.49%-0.34%+8.01%+9.73%
Cencora, Inc. stock logo
COR
Cencora
-2.68%+0.99%+3.10%+9.36%+6.93%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-4.09%-2.13%-11.36%-9.20%-6.02%
McKesson Co. stock logo
MCK
McKesson
-1.93%+0.08%+6.23%+10.64%+20.65%
Remove Ads

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.8901 of 5 stars
3.43.04.23.63.01.72.5
Cencora, Inc. stock logo
COR
Cencora
4.1714 of 5 stars
1.44.03.33.12.83.31.3
Henry Schein, Inc. stock logo
HSIC
Henry Schein
4.0687 of 5 stars
3.33.00.03.43.31.70.6
McKesson Co. stock logo
MCK
McKesson
4.439 of 5 stars
2.53.03.33.03.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.71
Moderate Buy$139.369.84% Upside
Cencora, Inc. stock logo
COR
Cencora
2.80
Moderate Buy$277.909.46% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.64
Moderate Buy$81.1015.96% Upside
McKesson Co. stock logo
MCK
McKesson
2.93
Moderate Buy$645.790.76% Upside

Current Analyst Ratings Breakdown

Latest MCK, COR, CAH, and HSIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/26/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$83.00 ➝ $80.00
2/26/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$90.00 ➝ $90.00
2/14/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$80.00
2/6/2025
Cencora, Inc. stock logo
COR
Cencora
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$270.00 ➝ $280.00
2/6/2025
McKesson Co. stock logo
MCK
McKesson
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$650.00 ➝ $675.00
2/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$140.00 ➝ $150.00
2/4/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$148.00
2/4/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$142.00 ➝ $145.00
2/4/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$135.00 ➝ $136.00
1/31/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$136.00 ➝ $142.00
1/30/2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$82.00 ➝ $90.00
(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$222.28B0.14$10.49 per share12.09($12.09) per share-10.49
Cencora, Inc. stock logo
COR
Cencora
$638.56M77.10$20.72 per share12.25$1.87 per share135.76
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.69$5.99 per share11.68$33.01 per share2.12
McKesson Co. stock logo
MCK
McKesson
$344.58B0.23$34.87 per share18.38($21.58) per share-29.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$5.3623.6714.181.490.59%-59.57%4.17%5/1/2025 (Estimated)
Cencora, Inc. stock logo
COR
Cencora
$1.51B$7.0336.1115.041.310.46%328.62%4.23%5/7/2025 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$416M$3.0428.7813.932.132.51%12.90%5.21%5/6/2025 (Estimated)
McKesson Co. stock logo
MCK
McKesson
$3.00B$21.8429.3517.491.290.82%-181.26%5.34%5/6/2025 (Estimated)

Latest MCK, COR, CAH, and HSIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/25/2025Q4 2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.23$1.19-$0.04$0.74$3.25 billion$3.19 billion
2/5/2025Q1 2025
Cencora, Inc. stock logo
COR
Cencora
$3.50$3.73+$0.23$2.50$78.22 billionN/A
2/5/2025Q3 2025
McKesson Co. stock logo
MCK
McKesson
$8.60$8.03-$0.57$6.95$95.86 billionN/A
1/30/2025Q2 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.74$1.93+$0.19$1.65$53.90 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.021.59%+1.00%37.69%28 Years
Cencora, Inc. stock logo
COR
Cencora
$2.200.87%+5.33%31.29%15 Years
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
McKesson Co. stock logo
MCK
McKesson
$2.840.44%+14.33%13.00%17 Years

Latest MCK, COR, CAH, and HSIC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/3/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50561.61%4/1/20254/1/20254/15/2025
1/30/2025
McKesson Co. stock logo
MCK
McKesson
quarterly$0.710.47%3/3/20253/3/20254/1/2025
2/5/2025
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.550.88%2/14/20252/14/20253/3/2025
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
1.02
0.54
Cencora, Inc. stock logo
COR
Cencora
16.40
0.92
0.54
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.46
1.42
0.82
McKesson Co. stock logo
MCK
McKesson
N/A
0.88
0.48

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Cencora, Inc. stock logo
COR
Cencora
97.52%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
McKesson Co. stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.09%
Cencora, Inc. stock logo
COR
Cencora
10.80%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.14%
McKesson Co. stock logo
MCK
McKesson
0.11%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,900241.57 million241.35 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
46,000193.92 million172.97 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
22,000124.18 million123.26 millionOptionable
McKesson Co. stock logo
MCK
McKesson
75,000125.33 million125.19 millionOptionable

Recent News About These Companies

McKesson Co. stock logo
McKesson (NYSE:MCK) Hits New 1-Year High - Time to Buy?
Six Sigma Meets IT at McKesson

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cardinal Health stock logo

Cardinal Health NYSE:CAH

$126.87 +2.70 (+2.18%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$126.84 -0.03 (-0.03%)
As of 03/12/2025 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora stock logo

Cencora NYSE:COR

$253.88 -6.79 (-2.60%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$253.98 +0.11 (+0.04%)
As of 03/12/2025 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$69.94 -2.98 (-4.09%)
Closing price 03/12/2025 04:00 PM Eastern
Extended Trading
$70.23 +0.29 (+0.42%)
As of 03/12/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

McKesson stock logo

McKesson NYSE:MCK

$640.93 -12.26 (-1.88%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$645.83 +4.90 (+0.77%)
As of 03/12/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.